In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine

Archives of Virology

Volumn 154, Issue 5, 2009, Pages 867-873

  Ma, Jian ^a,b   Jiang, Chenggang ^a   Lin, Yuezhi ^a   Wang, Xuefeng ^a   Zhao, Liping ^a   Xiang, Wenhua ^a   Shao, Yiming ^c   Shen, Rongxian ^a   Kong, Xiangang ^a   Zhou, Jianhua ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b NORTHEAST FORESTRY UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS;

GLYCOPROTEIN; LIVE VACCINE; SU PROTEIN, EQUINE INFECTIOUS ANEMIA VIRUS; VIRUS ENVELOPE PROTEIN; VIRUS RNA; VIRUS VACCINE;

ANIMAL; ARTICLE; EQUINE INFECTIOUS ANEMIA VIRUS; GENETICS; HORSE; HORSE DISEASE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MUTATION; PHYLOGENY; PHYSIOLOGY; VIROLOGY; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; EQUINE INFECTIOUS ANEMIA; GENES, VIRAL; GLYCOPROTEINS; HORSES; IMMUNOSUPPRESSION; INFECTIOUS ANEMIA VIRUS, EQUINE; MUTATION; PHYLOGENY; RNA, VIRAL; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; VIRAL VACCINES; VIRUS REPLICATION;

EID: 65549141157     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-009-0378-9     Document Type: Article

References (37)

1. N Almond K Kent M Cranage E Rud B Clarke EJ Stott 1995 Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells Lancet 345 1342 1344
2. JM Ball CL Swaggerty X Pei WS Lim X Xu VC Cox SL Payne 2005 SU proteins from virulent and avirulent EIAV demonstrate distinct biological properties Virology 333 132 144 (Pubitemid 40222197)
3. DH Barouch 2008 Challenges in the development of an HIV-1 vaccine Nature 455 613 619
4. RF Cook SL Berger KE Rushlow JM McManus SJ Cook S Harrold ML Raabe RC Montelaro CJ Issel 1995 Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein J Virol 69 1493 1499
5. JK Craigo S Durkin TJ Sturgeon T Tagmyer SJ Cook CJ Issel RC Montelaro 2007 Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines Vaccine 25 834 845
6. JK Craigo F Li JD Steckbeck S Durkin L Howe SJ Cook C Issel RC Montelaro 2005 Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy J Viro l79 2666 2677 (Pubitemid 40270545)
7. JK Craigo TJ Sturgeon SJ Cook CJ Issel C Leroux RC Montelaro 2006 Apparent elimination of EIAV ancestral species in a long-term inapparent carrier Virology 344 340 353 (Pubitemid 43049622)
8. JK Craigo B Zhang S Barnes TL Tagmyer SJ Cook CJ Issel RC Montelaro 2007 Envelope variation as a primary determinant of lentiviral vaccine efficacy Proc Natl Acad Sci 104 15105 15110 (Pubitemid 47619600)
9. MD Daniel F Kirchhoff SC Czajak PK Sehgal RC Desrosiers 1992 Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene Science 258 1938 1941 (Pubitemid 23026733)
10. AJ Fagerness MT Flaherty ST Perry B Jia SL Payne FJ Fuller 2006 The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies Virology 349 22 30
11. R Hofmann-Lehmann J Vlasak AL Williams AL Chenine HM McClure DC Anderson S O'Neil RM Ruprecht 2003 Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation Aids 17 157 166 (Pubitemid 36183040)
12. L Howe C Leroux CJ Issel RC Montelaro 2002 Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype J Virol 76 10588 10597 (Pubitemid 35176175)
13. RC Knowles 1984 An overview of equine infectious anemia control and regulation in the United States J Am Vet Med Assoc 184 289 292
14. WC Koff PR Johnson DI Watkins DR Burton JD Lifson KJ Hasenkrug AB McDermott A Schultz TJ Zamb R Boyle RC Desrosiers 2006 HIV vaccine design: insights from live attenuated SIV vaccines Nat Immunol 7 19 23 (Pubitemid 41823864)
15. F Li JK Craigo L Howe JD Steckbeck S Cook C Issel RC Montelaro 2003 A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses J Virol 77 7244 7253 (Pubitemid 36734493)
16. H Li X Zhang X Fan T Shen X Tong R Shen Y Shao 2005 A conservative domain shared by HIV gp120 and EIAV gp90: implications for HIV vaccine design AIDS Res Hum Retroviruses 21 1057 1059 (Pubitemid 43069190)
17. Y Li B Cleveland I Klots B Travis BA Richardson D Anderson D Montefiori P Polacino SL Hu 2008 Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses J Virol 82 638 651
18. H Liang X He RX Shen T Shen X Tong Y Ma WH Xiang XY Zhang YM Shao 2006 Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV Arch Virol 151 1387 1403 (Pubitemid 43962153)
19. P Polacino V Stallard JE Klaniecki DC Montefiori AJ Langlois BA Richardson J Overbaugh WR Morton RE Benveniste SL Hu 1999 Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen J Virol 73 618 630 (Pubitemid 28565406)
20. KA Reimann JT Li R Veazey M Halloran IW Park GB Karlsson J Sodroski NL Letvin 1996 A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys J Virol 70 6922 6928 (Pubitemid 26307405)
21. JN Reitter RE Means RC Desrosiers 1998 A role for carbohydrates in immune evasion in AIDS Nat. Med 4 679 684 (Pubitemid 28274667)
22. E Scherer D Douek A McMichael 2008 A 25 years of HIV research on virology, virus restriction, immunopathogenesis, genes and vaccines Clin Exp Immunol 154 6 14
23. Shen RX (1983) Development and use of an Equine Infectious anemia Donkey leucocyte attenuated vaccine. Proceedings of the international symposium on immunity to Equine infectious anemia. pp 21-53
24. Shen RX, Wang Z (1985) Development and use of an equine infectious anemia donkey leucocyte attenuated vaccine. EIAV: a national review of policies, programs, and future objectives. American Quarter Horse Association, Amarillo, pp 135-148
25. Shen RX, Wang ZY, Dong JP, et al. (2003) Fetal donkey dermal cells adapted attenuated vaccine of equine infectious anemia virus and its culture method (Chinese patent No. 01123620)
26. RX Shen ZD Xu XS He 1979 Study on immunological methods of equineinfectious anemia China Agric Sci 4 1 15
27. T Shen H Liang X Tong X Fan X He Y Ma W Xiang R Shen X Zhang Y Shao 2006 Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence Vaccine 24 738 749 (Pubitemid 43190080)
28. WO Sparks KS Dorman S Liu S Carpenter 2008 Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity J Gen Virol 89 1043 1048
29. C Stahl-Hennig U Dittmer T Nisslein K Pekrun H Petry E Jurkiewicz D Fuchs H Wachter EW Rud G Hunsmann 1996 Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion Immunol Lett 51 129 135 (Pubitemid 26227483)
30. BS Thompson TC Mitchell 2004 Measurement of daughter cell accumulation during lymphocyte proliferation in vivo J Immunol Methods 295 79 87 (Pubitemid 41057770)
31. DB Tumas MT Hines LE Perryman WC Davis TC McGuire 1994 Corticosteroid immunosuppression and monoclonal antibody-mediated CD5+ T lymphocyte depletion in normal and equine infectious anaemia virus-carrier horses J Gen Virol 75 959 968 (Pubitemid 24143140)
32. L Wang G Tong H Liu Z Yang H Qiu X Kong M Wang 2002 Proviral genomic sequence analysis of Chinese donkey leukocyte attenuated equine infectious anemia virus vaccine and its parental virus strain Liaoning Sci China C Life Sci 45 57 67 (Pubitemid 34231376)
33. AM Whatmore N Cook GA Hall S Sharpe EW Rud MP Cranage 1995 Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence J Virol 69 5117 5123
34. JB Whitney RM Ruprecht 2004 Live attenuated HIV vaccines: pitfalls and prospects Curr Opin Infect Dis 17 17 26 (Pubitemid 39089968)
35. MS Wyand KH Manson M Garcia-Moll D Montefiori RC Desrosiers 1996 Vaccine protection by a triple deletion mutant of simian immunodeficiency virus J Virol 70 3724 3733 (Pubitemid 26157352)
36. MS Wyand K Manson DC Montefiori JD Lifson RP Johnson RC Desrosiers 1999 Protection by live, attenuated simian immunodeficiency virus against heterologous challenge J Virol 73 8356 8363 (Pubitemid 29441697)
37. T Zhou XF Yuan SH Hou YB Tu JM Peng JX Wen HJ Qiu DL Wu HC Chen XJ Wang GZ Tong 2007 Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities Virus Res 128 58 64 (Pubitemid 47242885)